Maria Rossing

3.3k total citations
92 papers, 1.7k citations indexed

About

Maria Rossing is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Maria Rossing has authored 92 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 33 papers in Cancer Research and 25 papers in Genetics. Recurrent topics in Maria Rossing's work include Cancer Genomics and Diagnostics (15 papers), BRCA gene mutations in cancer (14 papers) and Platelet Disorders and Treatments (12 papers). Maria Rossing is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), BRCA gene mutations in cancer (14 papers) and Platelet Disorders and Treatments (12 papers). Maria Rossing collaborates with scholars based in Denmark, Sweden and United States. Maria Rossing's co-authors include Finn Cilius Nielsen, Lennart Friis‐Hansen, Martin Glud, Bodil Norrild, Christel Bræmer Lajer, Lena Specht, Christian von Buchwald, Emilie Garnæs, Marianne Hamilton Therkildsen and Christian Godballe and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Maria Rossing

82 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Rossing Denmark 22 812 708 320 262 254 92 1.7k
Emma Tham Sweden 19 470 0.6× 373 0.5× 115 0.4× 237 0.9× 359 1.4× 59 1.2k
Matthias S. Dettmer Switzerland 21 504 0.6× 263 0.4× 445 1.4× 407 1.6× 552 2.2× 65 1.6k
Kandelaria M. Rumilla United States 21 339 0.4× 278 0.4× 223 0.7× 217 0.8× 499 2.0× 38 1.2k
Pankaj K. Agarwalla United States 18 368 0.5× 175 0.2× 305 1.0× 314 1.2× 238 0.9× 53 1.5k
Hans-Jürgen Holzhausen Germany 26 562 0.7× 330 0.5× 464 1.4× 327 1.2× 612 2.4× 71 2.0k
Andres Ferbér United States 17 901 1.1× 272 0.4× 604 1.9× 156 0.6× 303 1.2× 38 1.5k
Rosa Fonti Italy 23 489 0.6× 289 0.4× 160 0.5× 150 0.6× 560 2.2× 65 1.6k
Nicole Pfarr Germany 29 601 0.7× 541 0.8× 185 0.6× 480 1.8× 1.2k 4.9× 98 2.4k
Ricardo González‐Cámpora Spain 23 488 0.6× 317 0.4× 298 0.9× 141 0.5× 502 2.0× 124 1.8k
Theresa Scognamiglio United States 27 660 0.8× 408 0.6× 1.2k 3.7× 188 0.7× 550 2.2× 108 2.4k

Countries citing papers authored by Maria Rossing

Since Specialization
Citations

This map shows the geographic impact of Maria Rossing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Rossing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Rossing more than expected).

Fields of papers citing papers by Maria Rossing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Rossing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Rossing. The network helps show where Maria Rossing may publish in the future.

Co-authorship network of co-authors of Maria Rossing

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Rossing. A scholar is included among the top collaborators of Maria Rossing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Rossing. Maria Rossing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frödin, Morten, et al.. (2025). Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects. Journal of Clinical Investigation. 135(12). 1 indexed citations
2.
Berg, Tobias, Lise Barlebo Ahlborn, Maj‐Britt Jensen, et al.. (2025). Comprehensive mapping elucidates high risk genotypes in primary metastatic breast cancer. Neoplasia. 63. 101162–101162.
3.
Jensen, Maj‐Britt, Bent Ejlertsen, Mads Thomassen, et al.. (2025). Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000. Acta Oncologica. 64. 147–155. 1 indexed citations
4.
Jensen, Maj‐Britt, Bent Ejlertsen, Mads Thomassen, et al.. (2025). Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study. Breast Cancer Research and Treatment. 212(2). 309–323.
5.
Berg, Tobias, Maj‐Britt Jensen, Maria Rossing, et al.. (2024). Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer. JAMA Network Open. 7(3). e242174–e242174. 4 indexed citations
6.
He, Yue, et al.. (2024). uPAR (PLAUR) Marks Two Intra-Tumoral Subtypes of Glioblastoma: Insights from Single-Cell RNA Sequencing. International Journal of Molecular Sciences. 25(4). 1998–1998. 2 indexed citations
7.
Fidalgo, José Alejandro Pérez, Barbara Schmalfeldt, Angela George, et al.. (2024). Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer. International Journal of Gynecological Cancer. 35(7). 101863–101863.
8.
Berg, Tobias, Maj‐Britt Jensen, Maj‐Lis Talman, et al.. (2024). Molecular subtyping improves breast cancer diagnosis in the Copenhagen Breast Cancer Genomics Study. JCI Insight. 9(7). 3 indexed citations
9.
10.
Lykkesfeldt, Jens, et al.. (2023). Reduced Vitamin C Levels in Patients with Bleeding of Unknown Cause and Generalized Joint Hypermobility. Blood. 142(Supplement 1). 25–25.
11.
Jensen, Maj‐Britt, Christina B. Pedersen, L.J. Gibson, et al.. (2023). Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer: a Copenhagen Breast Cancer Genomics Study. npj Breast Cancer. 9(1). 47–47. 4 indexed citations
12.
He, Yue, et al.. (2023). Quantitative Evaluation of Stem-like Markers of Human Glioblastoma Using Single-Cell RNA Sequencing Datasets. Cancers. 15(5). 1557–1557. 7 indexed citations
13.
Rossing, Maria, et al.. (2023). Detection of circulating tumor-derived material in peripheral blood of pediatric sarcoma patients: A systematic review. Translational Oncology. 34. 101690–101690. 7 indexed citations
14.
Rossing, Maria, Christina B. Pedersen, Tove Filtenborg Tvedskov, et al.. (2021). Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status. Scientific Reports. 11(1). 2259–2259. 21 indexed citations
15.
Leinøe, Eva, et al.. (2020). A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family. Blood Coagulation & Fibrinolysis. 31(7). 481–484.
16.
Zetterberg, Eva, Maria Rossing, Tina Manon‐Jensen, et al.. (2020). Collagen remodelling and plasma ascorbic acid levels in patients suspected of inherited bleeding disorders harbouring germline variants in collagen‐related genes. Haemophilia. 27(1). e69–e77. 3 indexed citations
17.
Mathiesen, Jes Sloth, Jens Peter Kroustrup, Peter Vestergaard, et al.. (2019). Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997–2014: A Nationwide Study. Thyroid. 29(3). 368–377. 43 indexed citations
18.
El‐Galaly, Tarec Christoffer, Karen Juul Mylam, Maria Rossing, et al.. (2013). Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse. Hematological Oncology. 31. 1 indexed citations
19.
Borup, Rehannah, Maria Rossing, Ricardo Henao, et al.. (2010). Molecular signatures of thyroid follicular neoplasia. Endocrine Related Cancer. 17(3). 691–708. 26 indexed citations
20.
Dreher, Anita, Maria Rossing, Bogumił Kaczkowski, Finn Cilius Nielsen, & Bodil Norrild. (2010). Differential expression of cellular microRNAs in HPV-11 transfected cells. An analysis by three different array platforms and qRT-PCR. Biochemical and Biophysical Research Communications. 403(3-4). 357–362. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026